[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360539-105":59,"doc-detail-360539-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","construction-of-a-homologous-targeting-exosome-based-drug-delivery-system-for-colorectal-cancer-and-evaluation-of-its-antitumor-efficacy","Construction of a homologous targeting exosome-based drug delivery system for colorectal cancer and evaluation of its antitumor efficacy","","A study constructs a homologous targeting exosome-based drug delivery system for colorectal cancer using tumor-derived exosomes as carriers for the chemotherapeutic SN38. Exosomes are isolated from HT29 colorectal cancer cells and NCM460 normal intestinal epithelial cells, characterized by NTA, TEM, and Western blotting, and loaded with SN38 via electroporation. Homologous targeting is validated through in vitro co-culture and in vivo live imaging, then antitumor efficacy is assessed by CCK-8 viability, flow-cytometry apoptosis, and a xenograft mouse model, showing markedly superior tumor inhibition.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/construction-of-a-homologous-targeting-exosome-based-drug-delivery-system-for-colorectal-cancer-and-evaluation-of-its-antitumor-efficacy/360539/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/construction-of-a-homologous-targeting-exosome-based-drug-delivery-system-for-colorectal-cancer-and-evaluation-of-its-antitumor-efficacy/360539.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"How are exosomes prepared and characterized in this study?","Question",{"text":113,"@type":114},"Exosomes are isolated from HT29 and NCM460 cells using differential ultracentrifugation, then characterized by nanoparticle tracking analysis, transmission electron microscopy, and Western blotting.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is SN38 loaded into the exosomes?",{"text":118,"@type":114},"SN38 is loaded into exosomes via electroporation to form the drug-loaded formulation used for downstream experiments.",{"name":120,"@type":111,"acceptedAnswer":121},"What evidence supports the homologous targeting effect?",{"text":122,"@type":114},"The study validates homologous targeting using in vitro cell co-culture experiments and in vivo live imaging, showing higher binding affinity and tumor accumulation for HT29-derived exosomes compared with controls.",{"name":124,"@type":111,"acceptedAnswer":125},"Which assays are used to evaluate antitumor efficacy and what is the key outcome?",{"text":126,"@type":114},"Antitumor efficacy is assessed using CCK-8 cell viability, flow cytometry apoptosis analysis, and a subcutaneous xenograft mouse model; the drug-loaded group shows the strongest growth inhibition, higher late apoptosis induction, and the lowest final tumor weight and volume.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},360539,1790288668,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nConstruction of a homologous targeting exosome-based drug delivery system for colorectal cancer and evaluation of its antitumor efficacy  \nShousen Shi1,4, Xiangyu Ma2,4, Ke Huang3, Leilei Ma3 & Wenbin Zhang1􀀍  \nThis study aimed to use the homologous targeting property of tumor-derived exosomes to construct a novel drug delivery system for SN38 and assess its enhanced therapeutic potential in colorectal cancer models. Exosomes were isolated from HT29 colorectal cancer cells (HT29-EXO) and NCM460 normal intestinal epithelial cells (NCM460-EXO) using differential ultracentrifugation, followed by characterization via nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and Western blotting (WB). The chemotherapeutic drug SN38 was subsequently loaded into the exosomes via electroporation. The homologous targeting capability of HT29-EXO was validated through both in vitro cell co-culture studies and in vivo live imaging. Finally, the antitumor efficacy of the drugloaded exosomes (HT29-EXO+SN38) was systematically evaluated using CCK-8 cell viability assays, flow cytometry-based apoptosis analysis, and a subcutaneous xenograft mouse model. This study conclusively demonstrates the superior homologous targeting of HT29-derived exosomes, showing  \n1.5-fold higher in vitro binding affinity and 2-fold greater in vivo tumor accumulation compared to control exosomes (NCM460-EXO). The therapeutic formulation HT29-EXO+SN38 proved significantly more effective. In vitro, it exhibited the strongest growth inhibition, reducing cell viability to 35.79% . Flow cytometry revealed that while total apoptosis rates were comparable, HT29-EXO+SN38 induced the highest rate of late apoptosis (41.57%, p \u003C 0.001 vs. others). These results were corroborated in vivo, where the HT29-EXO+SN38 group showed the most potent efficacy, achieving the lowest final tumor weight (182.0 ± 36.33 mg) and smallest volume (103.1 ± 36.8 mm³), with significant differences versus all other groups (p \u003C 0.05). Utilizing homologous tumor-derived exosomes as drug carriers enhances tumor inhibition by their superior targeting of parental cells and tissues.  \nKeywords Homing ability, Exosomes, Targeted drugs, Apoptosis, Cancer treatment  \nAccording to estimates from the International Agency for Research on Cancer (IARC) under the World Health Organization, there were approximately 1.93 million new cases of colorectal cancer (CRC) globally in 2025 (ranking third in incidence), with about 900,000 deaths (ranking second in mortality)1,2. As the number of people diagnosed with CRC continues to rise, surgery remains the primary therapeutic approach for nonmetastatic cases3. However, CRC is highly prone to metastasis, which often precludes surgical intervention and leads to recurrence or metastasis in nearly half of patients even after successful surgery, ultimately resulting in high mortality4. To address the critical need to inhibit tumor recurrence and metastasis, chemotherapy remains a cornerstone treatment for advanced disease. SN38 (7-ethyl-10-hydroxycamptothecin) is a potent topoisomerase I inhibitor that induces DNA damage in tumor cells and triggers apoptosis by disrupting DNA replication, transcription, recombination, and repair processes5. However, its efficacy is often compromised by  \n1Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xinshi District, Urumqi 830000, Xinjiang, China. 2Core Laboratory, The Affiliated Luoyang Central Hospital of Zhengzhou University, No. 288 Zhongzhou Middle Road, Xigong District, Luoyang 471000, Henan, China. 3Department of Endocrinology, The Affiliated Luoyang Central Hospital of Zhengzhou University, No. 288 Zhongzhou Middle Road, Xigong District, Luoyang 471000, Henan, China. 4Shousen Shi and Xiangyu Ma indicates equal contribution to the manuscript. These authors a","cbCailI2GyVSpXIV","https://ap.wps.com/l/cbCailI2GyVSpXIV","pdf",9889914,13,"English","# Introduction\n## Rationale and clinical need for improved colorectal cancer therapy\n## Role and limitations of SN38 chemotherapy\n## Exosomes as drug delivery nanocarriers\n# Methods and system construction\n## Exosome isolation and characterization\n## SN38 loading by electroporation\n## Homologous targeting validation\n# Antitumor efficacy evaluation\n## In vitro viability and apoptosis assays\n## In vivo xenograft efficacy outcomes","[{\"question\":\"How are exosomes prepared and characterized in this study?\",\"answer\":\"Exosomes are isolated from HT29 and NCM460 cells using differential ultracentrifugation, then characterized by nanoparticle tracking analysis, transmission electron microscopy, and Western blotting.\"},{\"question\":\"How is SN38 loaded into the exosomes?\",\"answer\":\"SN38 is loaded into exosomes via electroporation to form the drug-loaded formulation used for downstream experiments.\"},{\"question\":\"What evidence supports the homologous targeting effect?\",\"answer\":\"The study validates homologous targeting using in vitro cell co-culture experiments and in vivo live imaging, showing higher binding affinity and tumor accumulation for HT29-derived exosomes compared with controls.\"},{\"question\":\"Which assays are used to evaluate antitumor efficacy and what is the key outcome?\",\"answer\":\"Antitumor efficacy is assessed using CCK-8 cell viability, flow cytometry apoptosis analysis, and a subcutaneous xenograft mouse model; the drug-loaded group shows the strongest growth inhibition, higher late apoptosis induction, and the lowest final tumor weight and volume.\"}]","Construction of a homologous targeting exosome-based drug delivery system for colorectal cancer and evaluation of its antitumor efficacy | PDF",1790140468,33,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/245219e17aa60a765ba292b38215bfbd.webp",983,1291,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcb6f2c869994ff07ad1954cf27fdcb6.webp",982,1290,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9e0dee11bd9f5018187fa5e4003ec04.webp",981,1289,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b601fff2f70e33bc78b094f10bf53b08.webp",980,1287]